September 2023

My lab: clinical diagnostic parasitology

Unit Manager Jayne Jones gives a guided tour of her laboratory at the Liverpool School of Tropical Medicine.

A better digital offering

Dan Nimmo, IBMS Head of Communications, provides an update on the new website and CPD system.

World Alzheimer’s month

Laboratory Manager Francis Yongblah talks through his personal experiences supporting service users with Alzheimer’s and dementia.

Sickle cell anaemia and thalassaemia: a review

Shahid Muhammad, a Chartered Scientist and academic at Coventry University, looks at the issues in relation to transfusion medicine.

The evolution of traditional medicine

From shamans and witches to contemporary use of medicinal plants and health tourism, Stephen Mortlock looks at traditional medicines through the ages.

Recent advances and updates in biomedical science

Deputy Editor Ian Paterson, from the Department of Oral and Craniofacial Sciences at the University of Malaya, summarises the articles recently published in the British Journal of Biomedical Science.

Point-of-care testing and the new ISO 15189:2022

David Ricketts, Alyson Bryant and Sarah Glover look at accreditation and point-of-care testing.

Blood pressure for predicting outcomes

A new method derived from standard blood pressure assessments can improve monitoring of critically ill patients with circulatory shock, it is reported.

Automated medical imaging for schistosomiasis diagnosis

Schistosomiasis, a parasitic disease affecting millions worldwide, poses a significant public health and economic burden, particularly in impoverished regions.

Antibiotic resistance linked to air pollution?

Reducing levels of harmful air pollution could help reduce antibiotic resistance, according to the first in-depth global analysis of possible links between the two.

AI model to determine where cancer originated

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment, because many cancer drugs are typically developed for specific cancer types.

Top